OSM (oncostatin M)

2003-02-01  

Identity

HGNC
LOCATION
22q12.2
LOCUSID
ALIAS
-
FUSION GENES

Other Information

Locus ID:

NCBI: 5008
MIM: 165095
HGNC: 8506
Ensembl: ENSG00000099985

Variants:

dbSNP: 5008
ClinVar: 5008
TCGA: ENSG00000099985
COSMIC: OSM

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000099985ENST00000215781P13725
ENSG00000099985ENST00000403389B5MCX1
ENSG00000099985ENST00000403463B5MC70

Expression (GTEx)

0
5
10
15
20
25
30
35
40
45

Pathways

PathwaySourceExternal ID
Cytokine-cytokine receptor interactionKEGGko04060
Jak-STAT signaling pathwayKEGGko04630
Cytokine-cytokine receptor interactionKEGGhsa04060
Jak-STAT signaling pathwayKEGGhsa04630
PI3K-Akt signaling pathwayKEGGhsa04151
PI3K-Akt signaling pathwayKEGGko04151
Immune SystemREACTOMER-HSA-168256
Cytokine Signaling in Immune systemREACTOMER-HSA-1280215
Signaling by InterleukinsREACTOMER-HSA-449147
Interleukin-6 family signalingREACTOMER-HSA-6783589
IL-6-type cytokine receptor ligand interactionsREACTOMER-HSA-6788467
Interleukin-4 and 13 signalingREACTOMER-HSA-6785807

References

Pubmed IDYearTitleCitations
381510202024Exercise-induced crosstalk between immune cells and adipocytes in humans: Role of oncostatin-M.1
389532142024The causal relationship between immune cells mediating FIT3L, CCL4, OSM, and skin-derived deteriorated tumors.1
381510202024Exercise-induced crosstalk between immune cells and adipocytes in humans: Role of oncostatin-M.1
389532142024The causal relationship between immune cells mediating FIT3L, CCL4, OSM, and skin-derived deteriorated tumors.1
366237762023Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps.2
368569192023Role of oncostatin-M in ECM remodeling and plaque vulnerability.8
370470672023Oncostatin M Contributes to Airway Epithelial Cell Dysfunction in Chronic Rhinosinusitis with Nasal Polyps.0
372479262023Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic Cancer Cells.0
374769312023Oncostatin M for characterizing the inflammatory burden and outcome of V-V ECMO in ARDS patients.0
380350992023Oncostatin M suppresses IL31RA expression in dorsal root ganglia and interleukin-31-induced itching.3
366237762023Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps.2
368569192023Role of oncostatin-M in ECM remodeling and plaque vulnerability.8
370470672023Oncostatin M Contributes to Airway Epithelial Cell Dysfunction in Chronic Rhinosinusitis with Nasal Polyps.0
372479262023Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic Cancer Cells.0
374769312023Oncostatin M for characterizing the inflammatory burden and outcome of V-V ECMO in ARDS patients.0

Citation

Dessen P

OSM (oncostatin M)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/41615/meetings/case-report-explorer/favicon/favicon-32x32.png